News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,336 Results
Type
Article (87049)
Company Profile (704)
Press Release (767570)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232904)
Career Advice (4134)
Deals (39771)
Drug Delivery (131)
Drug Development (91147)
Employer Resources (200)
FDA (18215)
Job Trends (17374)
News (397017)
Policy (39855)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (123)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (192)
Approvals (18182)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (415)
Cancer (3280)
Cardiovascular disease (263)
Career advice (3543)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (601)
Cervical cancer (26)
Clinical research (74584)
Collaboration (1176)
Company closure (4)
Compensation (787)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (414)
Cystic fibrosis (126)
Data (3345)
Decentralized trials (2)
Denatured (55)
Depression (84)
Diabetes (390)
Diagnostics (7010)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (162)
Drug shortages (36)
Duchenne muscular dystrophy (170)
Earnings (98372)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131729)
Executive appointments (932)
FDA (20259)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1056)
Gene editing (154)
Generative AI (42)
Gene therapy (473)
GLP-1 (961)
Government (5303)
Grass and pollen (7)
Guidances (321)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (137)
Interviews (813)
IPO (17909)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (609)
Leadership (27)
Legal (10140)
Liver cancer (87)
Longevity (12)
Lung cancer (455)
Lymphoma (232)
Machine learning (16)
Management (65)
Manufacturing (497)
MASH (106)
Medical device (14771)
Medtech (14782)
Mergers & acquisitions (22634)
Metabolic disorders (999)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2434)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (51)
Obesity (506)
Opinion (298)
Ovarian cancer (108)
Pain (134)
Pancreatic cancer (136)
Parkinson's disease (208)
Partnered (26)
Patents (350)
Patient recruitment (204)
Peanut (55)
People (65860)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23004)
Phase II (32376)
Phase III (24394)
Pipeline (2121)
Policy (261)
Postmarket research (3554)
Preclinical (10396)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (553)
Real estate (7403)
Recruiting (76)
Regulatory (27397)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (111)
Series A (176)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (954)
Venture capital (62)
Weight loss (346)
Women's health (53)
Worklife (20)
Date
Today (159)
Last 7 days (778)
Last 30 days (2581)
Last 365 days (33923)
2025 (20875)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (285)
Arkansas (14)
Asia (50638)
Australia (8896)
California (8313)
Canada (2538)
China (761)
Colorado (355)
Connecticut (370)
Delaware (223)
Europe (116258)
Florida (1244)
Georgia (281)
Hawaii (3)
Idaho (67)
Illinois (767)
India (35)
Indiana (407)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1163)
Massachusetts (6336)
Michigan (283)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (90)
New Hampshire (75)
New Jersey (2308)
New Mexico (31)
New York (2293)
North Carolina (1294)
North Dakota (10)
Northern California (3638)
Ohio (266)
Oklahoma (17)
Oregon (48)
Pennsylvania (1775)
Puerto Rico (18)
Rhode Island (41)
South America (1654)
South Carolina (38)
South Dakota (1)
Southern California (3119)
Tennessee (136)
Texas (1275)
United States (31162)
Utah (242)
Virginia (224)
Washington D.C. (80)
Washington State (719)
West Virginia (4)
Wisconsin (89)
There are 855,336 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
The High Stakes Tradeoffs of a ‘Most Favored Nation’ Drug Policy
President Donald Trump loves a deal, but Most Favored Nation drug pricing isn’t a good one for anyone.
August 13, 2025
·
3 min read
·
Fred Roeder
Legal
Texas Accuses Lilly of ‘Bribing’ Prescribers to Push Mounjaro, Zepbound in New Suit
Texas Attorney General Ken Paxton claims that through an alleged kickback scheme Eli Lilly “fraudulently sought to maximize profits at taxpayer expense.”
August 13, 2025
·
2 min read
·
Tristan Manalac
Approvals
Insmed Wins Approval For First Bronchiectasis Drug and DPP1 Blocker
Insmed’s Brinsupri is the first DPP1 inhibitor approved by the FDA and the first treatment for bronchiectasis to reach the market.
August 13, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Sarepta Provides New Elevidys Safety Data, Reveals Zero Ambulatory Deaths
Jefferies analysts said these detailed safety outcomes confirm the gene therapy’s positive risk/benefit profile in ambulatory patients with Duchenne muscular dystrophy.
August 13, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Biotech Contraction Continues as Absci, Fate, Oric Downsize
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 13, 2025
·
185 min read
·
BioSpace Editorial Staff
Press Releases
Glaukos Announces Participation in Wells Fargo Healthcare Conference 2025
August 13, 2025
·
1 min read
Press Releases
Satellos Reports Second Quarter 2025 Results and Highlights Upcoming Clinical Milestones
August 13, 2025
·
9 min read
Press Releases
Health Canada Approves KEYTRUDA® for Patients with Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma Tumours that are PD-L1 (CPS) Positive as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as Monotherapy
August 13, 2025
·
8 min read
Press Releases
Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
August 13, 2025
·
20 min read
Press Releases
PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update
August 13, 2025
·
9 min read
1 of 85,534
Next
